 Betsy Risendal
Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 18 | 2023 | 2179 | 2.490 |
Why?
| | Cancer Survivors | 5 | 2023 | 201 | 2.180 |
Why?
| | Patient Navigation | 4 | 2022 | 77 | 2.030 |
Why?
| | Survivors | 12 | 2015 | 418 | 1.770 |
Why?
| | Breast Neoplasms | 23 | 2022 | 1965 | 1.530 |
Why?
| | Colorectal Neoplasms | 7 | 2022 | 628 | 1.450 |
Why?
| | Community-Based Participatory Research | 1 | 2023 | 133 | 0.840 |
Why?
| | Delivery of Health Care | 8 | 2023 | 867 | 0.800 |
Why?
| | Health Plan Implementation | 3 | 2018 | 133 | 0.770 |
Why?
| | Early Detection of Cancer | 7 | 2023 | 360 | 0.710 |
Why?
| | Patient Care Planning | 4 | 2015 | 143 | 0.620 |
Why?
| | Patient Advocacy | 1 | 2017 | 66 | 0.590 |
Why?
| | Quality of Life | 4 | 2023 | 2366 | 0.560 |
Why?
| | Specialization | 1 | 2015 | 120 | 0.490 |
Why?
| | Registries | 2 | 2020 | 1810 | 0.440 |
Why?
| | Physicians, Primary Care | 1 | 2015 | 222 | 0.420 |
Why?
| | Health Equity | 2 | 2023 | 56 | 0.420 |
Why?
| | Self Care | 1 | 2014 | 357 | 0.410 |
Why?
| | Research Design | 3 | 2023 | 969 | 0.410 |
Why?
| | Mass Screening | 6 | 2022 | 1052 | 0.400 |
Why?
| | Humans | 54 | 2023 | 118974 | 0.390 |
Why?
| | Adaptation, Psychological | 1 | 2014 | 557 | 0.370 |
Why?
| | Cross-Sectional Studies | 10 | 2020 | 4552 | 0.370 |
Why?
| | Health Knowledge, Attitudes, Practice | 5 | 2014 | 1185 | 0.370 |
Why?
| | Middle Aged | 29 | 2022 | 27617 | 0.360 |
Why?
| | Indians, North American | 3 | 1999 | 598 | 0.360 |
Why?
| | Chronic Disease | 2 | 2015 | 1636 | 0.350 |
Why?
| | Patient-Centered Care | 1 | 2014 | 497 | 0.350 |
Why?
| | Weight Gain | 1 | 2013 | 493 | 0.350 |
Why?
| | Aged | 21 | 2022 | 19657 | 0.340 |
Why?
| | Surveys and Questionnaires | 9 | 2022 | 4708 | 0.320 |
Why?
| | Program Evaluation | 4 | 2022 | 845 | 0.310 |
Why?
| | Logistic Models | 10 | 2019 | 1901 | 0.310 |
Why?
| | Family Health | 1 | 2008 | 201 | 0.310 |
Why?
| | Continuity of Patient Care | 3 | 2015 | 265 | 0.300 |
Why?
| | Safety-net Providers | 2 | 2018 | 96 | 0.300 |
Why?
| | Quality of Health Care | 1 | 2011 | 586 | 0.290 |
Why?
| | Practice Patterns, Physicians' | 1 | 2015 | 1200 | 0.290 |
Why?
| | Female | 35 | 2022 | 61565 | 0.280 |
Why?
| | Case-Control Studies | 7 | 2020 | 3171 | 0.280 |
Why?
| | Capacity Building | 2 | 2023 | 51 | 0.280 |
Why?
| | Mammography | 3 | 2010 | 126 | 0.270 |
Why?
| | Primary Health Care | 4 | 2022 | 1560 | 0.260 |
Why?
| | Survivorship | 2 | 2022 | 38 | 0.250 |
Why?
| | Adult | 25 | 2019 | 31512 | 0.250 |
Why?
| | Odds Ratio | 5 | 2013 | 996 | 0.250 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2014 | 216 | 0.250 |
Why?
| | Arizona | 4 | 2013 | 69 | 0.240 |
Why?
| | Exercise | 1 | 2014 | 1657 | 0.240 |
Why?
| | Healthcare Disparities | 3 | 2017 | 496 | 0.210 |
Why?
| | United States | 14 | 2023 | 12555 | 0.210 |
Why?
| | Risk Factors | 13 | 2023 | 9000 | 0.200 |
Why?
| | Papanicolaou Test | 1 | 1999 | 40 | 0.180 |
Why?
| | Vaginal Smears | 1 | 1999 | 49 | 0.180 |
Why?
| | Health Priorities | 1 | 1999 | 34 | 0.170 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2220 | 0.170 |
Why?
| | Unemployment | 1 | 2019 | 42 | 0.170 |
Why?
| | Research | 3 | 2018 | 411 | 0.170 |
Why?
| | Patient Education as Topic | 2 | 2014 | 699 | 0.160 |
Why?
| | Congresses as Topic | 1 | 2019 | 204 | 0.150 |
Why?
| | Age Factors | 7 | 2019 | 2995 | 0.150 |
Why?
| | Follow-Up Studies | 3 | 2015 | 4596 | 0.150 |
Why?
| | Preventive Medicine | 1 | 2017 | 39 | 0.150 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 193 | 0.140 |
Why?
| | Public Health | 1 | 2021 | 450 | 0.140 |
Why?
| | Health Planning | 1 | 2015 | 46 | 0.130 |
Why?
| | Comorbidity | 1 | 2020 | 1527 | 0.130 |
Why?
| | Health Status | 1 | 2020 | 726 | 0.130 |
Why?
| | Pediatric Obesity | 1 | 2022 | 524 | 0.130 |
Why?
| | Community Health Centers | 1 | 2014 | 57 | 0.130 |
Why?
| | Transition to Adult Care | 1 | 2015 | 58 | 0.130 |
Why?
| | Patient Acceptance of Health Care | 2 | 2018 | 687 | 0.120 |
Why?
| | Diagnostic Tests, Routine | 1 | 2015 | 88 | 0.120 |
Why?
| | Anniversaries and Special Events | 1 | 2014 | 13 | 0.120 |
Why?
| | Disease Management | 2 | 2015 | 571 | 0.120 |
Why?
| | Diffusion of Innovation | 1 | 2014 | 98 | 0.120 |
Why?
| | Health Behavior | 1 | 1999 | 720 | 0.120 |
Why?
| | Ambulatory Care Facilities | 1 | 2015 | 218 | 0.120 |
Why?
| | Medical Oncology | 1 | 2015 | 229 | 0.110 |
Why?
| | Health Promotion | 2 | 2023 | 691 | 0.110 |
Why?
| | Genetic Testing | 1 | 2015 | 389 | 0.110 |
Why?
| | Body Weight | 2 | 2013 | 934 | 0.110 |
Why?
| | Age of Onset | 2 | 2019 | 467 | 0.110 |
Why?
| | Incidence | 4 | 2019 | 2424 | 0.110 |
Why?
| | New Mexico | 1 | 2013 | 67 | 0.110 |
Why?
| | Receptors, Estrogen | 3 | 2013 | 387 | 0.110 |
Why?
| | Vitamin B Complex | 1 | 2013 | 37 | 0.110 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2012 | 44 | 0.110 |
Why?
| | Health Services Accessibility | 2 | 2014 | 781 | 0.110 |
Why?
| | Health Personnel | 1 | 2018 | 588 | 0.110 |
Why?
| | Methionine | 1 | 2013 | 145 | 0.110 |
Why?
| | Folic Acid | 1 | 2013 | 161 | 0.100 |
Why?
| | Socioeconomic Factors | 4 | 2013 | 1129 | 0.100 |
Why?
| | Feasibility Studies | 1 | 2014 | 749 | 0.100 |
Why?
| | Prognosis | 3 | 2022 | 3443 | 0.100 |
Why?
| | Male | 7 | 2020 | 57801 | 0.100 |
Why?
| | Patient Participation | 1 | 2014 | 369 | 0.100 |
Why?
| | Obesity | 3 | 2013 | 2746 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2015 | 610 | 0.100 |
Why?
| | Guideline Adherence | 1 | 2015 | 523 | 0.100 |
Why?
| | Survival Rate | 2 | 2011 | 1720 | 0.090 |
Why?
| | Interviews as Topic | 2 | 2013 | 599 | 0.090 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 38 | 0.090 |
Why?
| | Southwestern United States | 4 | 2011 | 94 | 0.090 |
Why?
| | Hydroxyestrones | 1 | 2009 | 3 | 0.090 |
Why?
| | Patient Care Team | 1 | 2014 | 521 | 0.090 |
Why?
| | Colorado | 3 | 2015 | 4196 | 0.080 |
Why?
| | Cohort Studies | 2 | 2022 | 5116 | 0.080 |
Why?
| | Confidence Intervals | 1 | 2008 | 324 | 0.080 |
Why?
| | Urinary Incontinence | 1 | 2008 | 61 | 0.080 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2009 | 287 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2014 | 1440 | 0.070 |
Why?
| | Parity | 2 | 2022 | 101 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 3 | 2010 | 2275 | 0.070 |
Why?
| | Multivariate Analysis | 2 | 1999 | 1474 | 0.070 |
Why?
| | Patient Compliance | 1 | 2009 | 537 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2018 | 2874 | 0.060 |
Why?
| | Psychometrics | 2 | 2018 | 631 | 0.060 |
Why?
| | Smoking | 2 | 2023 | 1487 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2009 | 1059 | 0.060 |
Why?
| | Phenotype | 1 | 2011 | 3003 | 0.060 |
Why?
| | School Teachers | 1 | 2022 | 18 | 0.050 |
Why?
| | Young Adult | 4 | 2019 | 10793 | 0.050 |
Why?
| | Prospective Studies | 1 | 2013 | 6471 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2012 | 2174 | 0.050 |
Why?
| | Alcohol Drinking | 2 | 2011 | 652 | 0.050 |
Why?
| | Postpartum Period | 1 | 2022 | 271 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2007 | 942 | 0.040 |
Why?
| | Body Mass Index | 3 | 2013 | 2092 | 0.040 |
Why?
| | School Health Services | 1 | 2022 | 203 | 0.040 |
Why?
| | Financing, Personal | 1 | 2019 | 27 | 0.040 |
Why?
| | Health Education | 1 | 2022 | 318 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2022 | 1125 | 0.040 |
Why?
| | Culture | 1 | 1999 | 129 | 0.040 |
Why?
| | Minority Groups | 1 | 2000 | 237 | 0.040 |
Why?
| | Schools | 1 | 2022 | 411 | 0.040 |
Why?
| | Pregnancy | 3 | 2022 | 5691 | 0.040 |
Why?
| | Risk | 2 | 2012 | 853 | 0.040 |
Why?
| | Menopause | 2 | 2011 | 266 | 0.040 |
Why?
| | Postmenopause | 2 | 2009 | 305 | 0.040 |
Why?
| | Factor Analysis, Statistical | 1 | 2018 | 270 | 0.040 |
Why?
| | Medicaid | 1 | 2021 | 411 | 0.040 |
Why?
| | Health Status Disparities | 1 | 2019 | 209 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 252 | 0.040 |
Why?
| | Cost of Illness | 1 | 2019 | 258 | 0.040 |
Why?
| | Intersectoral Collaboration | 1 | 2017 | 60 | 0.040 |
Why?
| | Patient Selection | 1 | 2000 | 676 | 0.040 |
Why?
| | Urban Population | 1 | 1999 | 409 | 0.040 |
Why?
| | Risk-Taking | 1 | 1999 | 319 | 0.040 |
Why?
| | Data Collection | 2 | 2014 | 658 | 0.040 |
Why?
| | Health Care Costs | 1 | 1999 | 394 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 2017 | 253 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 663 | 0.030 |
Why?
| | Prejudice | 1 | 2015 | 56 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 385 | 0.030 |
Why?
| | Cancer Care Facilities | 1 | 2015 | 35 | 0.030 |
Why?
| | Poverty | 1 | 2018 | 444 | 0.030 |
Why?
| | Poverty Areas | 1 | 2014 | 35 | 0.030 |
Why?
| | Organizational Innovation | 1 | 2015 | 138 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 191 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2015 | 208 | 0.030 |
Why?
| | Insurance, Health | 1 | 2015 | 244 | 0.030 |
Why?
| | Program Development | 1 | 2015 | 357 | 0.030 |
Why?
| | Prevalence | 2 | 2010 | 2326 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2015 | 6561 | 0.030 |
Why?
| | National Cancer Institute (U.S.) | 1 | 2011 | 43 | 0.030 |
Why?
| | Child | 3 | 2022 | 19129 | 0.030 |
Why?
| | Sickness Impact Profile | 1 | 2011 | 51 | 0.030 |
Why?
| | Adolescent | 3 | 2019 | 18480 | 0.020 |
Why?
| | Haplotypes | 1 | 2012 | 473 | 0.020 |
Why?
| | Population Surveillance | 1 | 2013 | 413 | 0.020 |
Why?
| | Premenopause | 1 | 2009 | 108 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2011 | 325 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2013 | 1223 | 0.020 |
Why?
| | Receptor, ErbB-2 | 1 | 2011 | 320 | 0.020 |
Why?
| | Decision Making | 1 | 2015 | 809 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 653 | 0.020 |
Why?
| | Body Size | 1 | 2009 | 94 | 0.020 |
Why?
| | Epidemiologic Methods | 1 | 2008 | 72 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 2011 | 502 | 0.020 |
Why?
| | Societies, Medical | 1 | 2011 | 703 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 525 | 0.020 |
Why?
| | Women's Health | 1 | 2009 | 274 | 0.020 |
Why?
| | Motor Activity | 1 | 2011 | 660 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 3057 | 0.020 |
Why?
| | Attitude to Health | 1 | 2009 | 410 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2021 | 12978 | 0.020 |
Why?
| | Diabetes, Gestational | 1 | 2007 | 284 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 9491 | 0.010 |
Why?
| | Cultural Characteristics | 1 | 2000 | 61 | 0.010 |
Why?
| | Language | 1 | 2000 | 271 | 0.010 |
Why?
|
|
Risendal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|